{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:53:31Z","timestamp":1790985211217,"version":"4.1.0"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shandong Province Higher Education Institutions Youth Innovation Team Development Plan","award":["2024Kjj013"],"award-info":[{"award-number":["2024Kjj013"]}]},{"name":"Young Talent of Lifting Engineering for Science and Technology in Shandong","award":["SDAST2024QTB034"],"award-info":[{"award-number":["SDAST2024QTB034"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12105160"],"award-info":[{"award-number":["12105160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12275162"],"award-info":[{"award-number":["12275162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Provincial Natural Science Foundation","award":["ZR2021QA099"],"award-info":[{"award-number":["ZR2021QA099"]}]},{"name":"Key Research and Development Program of Xinjiang Uygur Autonomous Region of China","award":["2022B03019-5"],"award-info":[{"award-number":["2022B03019-5"]}]},{"name":"Taishan Scholars Project of Shandong Province","award":["ts201712098"],"award-info":[{"award-number":["ts201712098"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This review summarizes preclinical evidence on the immunomodulatory mechanisms of spatially fractionated radiotherapy (SFRT) alone and in combination with immune checkpoint inhibitors (ICIs), as well as clinical evidence for SFRT with or without immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>Conventional radiotherapy (CRT) has a dual impact on anti-tumor immunity, simultaneously activating immune responses and inducing immunosuppression. Preclinical studies show that SFRT can remodel the tumor microenvironment (TME) and tumor vasculature, enhance effector immune cell infiltration, regulate cytokine networks, and elicit both bystander and abscopal effects. However, the magnitude and direction of these effects vary substantially across SFRT modalities, parameters, and tumor types.When combined with ICIs, SFRT shows promising tumor-control activity in preclinical models, yet it does not consistently outperform CRT plus ICI. Clinical evidence is still limited to small palliative cohorts and case reports without systematic immune monitoring. Nonetheless, isolated cases have reported abscopal responses and reversal of ICI resistance, highlighting the need for prospective, biomarker\u2011driven studies to define the immunologic and clinical role of SFRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Preclinical evidence suggests that SFRT can induce both bystander and abscopal effects. These effects may help overcome immune resistance when SFRT is combined with immunotherapy, ultimately improving the therapeutic ratio of radiation and enhancing the efficacy of ICIs. However, current clinical data are still preliminary, and further systematic research is needed to optimize SFRT parameters, treatment sequencing, and tumor-specific responses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08548-6","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:05:52Z","timestamp":1783505152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatially fractionated radiotherapy and immunotherapy: a synergistic strategy for systemic anti-tumor immunity"],"prefix":"10.1186","volume":"24","author":[{"given":"MengYao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maojie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0741-7023","authenticated-orcid":false,"given":"Yong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"8548_CR1","doi-asserted-by":"publisher","first-page":"111035","DOI":"10.1016\/j.radonc.2025.111035","volume":"210","author":"I Meattini","year":"2025","unstructured":"Meattini I, Aznar MC, Boldrini L, Borgmann K, Clark CH, Faivre-Finn C, et al. Repositioning radiation oncology at the centre of integrated oncology care: A manifesto of the european society for radiotherapy and oncology (ESTRO). Radiother Oncol. 2025;210:111035. https:\/\/doi.org\/10.1016\/j.radonc.2025.111035.","journal-title":"Radiother Oncol"},{"key":"8548_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41416-020-0942-3","volume":"123","author":"E Daguenet","year":"2020","unstructured":"Daguenet E, Louati S, Wozny A-S, Vial N, Gras M, Guy J-B, et al. Radiation-induced bystander and abscopal effects: Important lessons from preclinical models. Br J Cancer. 2020;123:339\u201348. https:\/\/doi.org\/10.1038\/s41416-020-0942-3.","journal-title":"Br J Cancer"},{"key":"8548_CR3","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1038\/cddis.2011.134","volume":"3","author":"MA Kang","year":"2012","unstructured":"Kang MA, So E-Y, Simons AL, Spitz DR, Ouchi T. DNA damage induces reactive oxygen species generation through the H2AX-Nox1\/Rac1 pathway. Cell Death Dis Springer Sci Bus Media LLC. 2012;3:e249\u2013249. https:\/\/doi.org\/10.1038\/cddis.2011.134.","journal-title":"Cell Death Dis Springer Sci Bus Media LLC"},{"key":"8548_CR4","first-page":"321","volume":"60","author":"LA Pe\u00f1a","year":"2000","unstructured":"Pe\u00f1a LA, Fuks Z, Kolesnick RN. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: Protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res. 2000;60:321\u20137.","journal-title":"Cancer Res"},{"key":"8548_CR5","doi-asserted-by":"publisher","first-page":"2057892","DOI":"10.1080\/2162402X.2022.2057892","volume":"11","author":"H Zhou","year":"2022","unstructured":"Zhou H, Tu C, Yang P, Li J, Kepp O, Li H, et al. Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice. OncoImmunology. 2022;11:2057892. https:\/\/doi.org\/10.1080\/2162402X.2022.2057892.","journal-title":"OncoImmunology"},{"key":"8548_CR6","doi-asserted-by":"publisher","first-page":"e28518","DOI":"10.4161\/onci.28518","volume":"3","author":"EB Golden","year":"2014","unstructured":"Golden EB, Frances D, Pellicciotta I, Demaria S, Helen Barcellos-Hoff M, Formenti SC. Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. OncoImmunology Informa UK Ltd. 2014;3:e28518. https:\/\/doi.org\/10.4161\/onci.28518.","journal-title":"OncoImmunology Informa UK Ltd"},{"key":"8548_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1667\/RR3819.1","volume":"182","author":"S Kanagavelu","year":"2014","unstructured":"Kanagavelu S, Gupta S, Wu X, Philip S, Wattenberg MM, Hodge JW, et al. In vivo effects of lattice radiation therapy on local and distant lung cancer: Potential role of immunomodulation. Radiat Res. 2014;182:149\u201362. https:\/\/doi.org\/10.1667\/RR3819.1.","journal-title":"Radiat Res"},{"key":"8548_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/153303460200100207","volume":"1","author":"S Sathishkumar","year":"2002","unstructured":"Sathishkumar S, Dey S, Meigooni AS, Regine WF, Kudrimoti M, Ahmed MM, et al. The impact of TNF-\u03b1 induction on therapeutic efficacy following high dose spatially fractionated (GRID) radiation. Technol Cancer Res Treat. 2002;1:141\u20137. https:\/\/doi.org\/10.1177\/153303460200100207.","journal-title":"Technol Cancer Res Treat"},{"key":"8548_CR9","doi-asserted-by":"publisher","first-page":"9709","DOI":"10.1073\/pnas.0603567103","volume":"103","author":"FA Dilmanian","year":"2006","unstructured":"Dilmanian FA, Zhong Z, Bacarian T, Benveniste H, Romanelli P, Wang R, et al. Interlaced x-ray microplanar beams: A radiosurgery approach with clinical potential. Proc Natl Acad Sci U S A. 2006;103:9709\u201314. https:\/\/doi.org\/10.1073\/pnas.0603567103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8548_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/neuonc\/4.1.26","volume":"4","author":"FA Dilmanian","year":"2002","unstructured":"Dilmanian FA, Button TM, Le Duc G, Zhong N, Pe\u00f1a LA, Smith JAL, et al. Response of rat intracranial 9L gliosarcoma to microbeam radiation therapy. Neuro Oncol. 2002;4:26\u201338. https:\/\/doi.org\/10.1093\/neuonc\/4.1.26.","journal-title":"Neuro Oncol"},{"key":"8548_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1667\/0033-7587(","volume":"159","author":"FA Dilmanian","year":"2003","unstructured":"Dilmanian FA, Morris GM, Zhong N, Bacarian T, Hainfeld JF, Kalef-Ezra J, et al. Murine EMT-6 carcinoma: High therapeutic efficacy of microbeam radiation therapy. Radiat Res. 2003;159:632\u201341. https:\/\/doi.org\/10.1667\/0033-7587(. 2003)159%5B0632:mechte%5D2.0.co;2.","journal-title":"Radiat Res"},{"key":"8548_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1259\/bjr\/50464795","volume":"79","author":"M Miura","year":"2006","unstructured":"Miura M, Blattmann H, Br\u00e4uer-Krisch E, Bravin A, Hanson AL, Nawrocky MM, et al. Radiosurgical palliation of aggressive murine SCCVII squamous cell carcinomas using synchrotron-generated X-ray microbeams. Br J Radiol. 2006;79:71\u20135. https:\/\/doi.org\/10.1259\/bjr\/50464795.","journal-title":"Br J Radiol"},{"key":"8548_CR13","doi-asserted-by":"publisher","unstructured":"Sabatasso S, Laissue JA, Hlushchuk R, Graber W, Bravin A, Braeuer-Krisch E et al. Microbeam radiation-induced tissue damage depends on the stage of vascular maturation. Int J Radiat Oncol Biol Phys. 2011;80:1522\u201332. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.03.018.","DOI":"10.1016\/j.ijrobp.2011.03.018"},{"key":"8548_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ijrobp.2022.08.011","volume":"115","author":"A Bertho","year":"2023","unstructured":"Bertho A, Iturri L, Brisebard E, Juchaux M, Gilbert C, Ortiz R, et al. Evaluation of the role of the immune system response after minibeam radiation therapy. Int J Radiation Oncology*Biology*Physics. 2023;115:426\u201339. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.08.011.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"8548_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/09553002.2013.766770","volume":"89","author":"C Fernandez-Palomo","year":"2013","unstructured":"Fernandez-Palomo C, Sch\u00fcltke E, Smith R, Br\u00e4uer-Krisch E, Laissue J, Schroll C, et al. Bystander effects in tumor-free and tumor-bearing rat brains following irradiation by synchrotron X-rays. Int J Radiat Biol. 2013;89:445\u201353. https:\/\/doi.org\/10.3109\/09553002.2013.766770.","journal-title":"Int J Radiat Biol"},{"key":"8548_CR16","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.ijrobp.2005.11.047","volume":"64","author":"R Serduc","year":"2006","unstructured":"Serduc R, V\u00e9rant P, Vial J-C, Farion R, Rocas L, R\u00e9my C, et al. In vivo two-photon microscopy study of short-term effects of microbeam irradiation on normal mouse brain microvasculature. Int J Radiation Oncology*Biology*Physics. 2006;64:1519\u201327. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.11.047.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"8548_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1088\/0031-9155\/53\/5\/001","volume":"53","author":"R Serduc","year":"2008","unstructured":"Serduc R, van de Looij Y, Francony G, Verdonck O, van der Sanden B, Laissue J, et al. Characterization and quantification of cerebral edema induced by synchrotron x-ray microbeam radiation therapy. Phys Med Biol. 2008;53:1153\u201366. https:\/\/doi.org\/10.1088\/0031-9155\/53\/5\/001.","journal-title":"Phys Med Biol"},{"key":"8548_CR18","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.ijrobp.2010.02.019","volume":"77","author":"B van der Sanden","year":"2010","unstructured":"van der Sanden B, Br\u00e4uer-Krisch E, Siegbahn EA, Ricard C, Vial J-C, Laissue J. Tolerance of arteries to microplanar X-ray beams. Int J Radiat Oncol Biol Phys. 2010;77:1545\u201352. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.02.019.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8548_CR19","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1107\/S0909049511011836","volume":"18","author":"CN Sprung","year":"2011","unstructured":"Sprung CN, Cholewa M, Usami N, Kobayashi K, Crosbie JC. DNA damage and repair kinetics after microbeam radiation therapy emulation in living cells using monoenergetic synchrotron X-ray microbeams. J Synchrotron Radiat. 2011;18:630\u20136. https:\/\/doi.org\/10.1107\/S0909049511011836.","journal-title":"J Synchrotron Radiat"},{"key":"8548_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/biomedicines10040735","volume":"10","author":"V Trappetti","year":"2022","unstructured":"Trappetti V, Fazzari J, Fernandez-Palomo C, Smyth L, Potez M, Shintani N, et al. Targeted accumulation of macrophages induced by microbeam irradiation in a tissue-dependent manner. Biomedicines. 2022;10:735. https:\/\/doi.org\/10.3390\/biomedicines10040735.","journal-title":"Biomedicines"},{"key":"8548_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/cancers14010155","volume":"14","author":"S Bazyar","year":"2021","unstructured":"Bazyar S, O\u2019Brien ET, Benefield T, Roberts VR, Kumar RJ, Gupta GP, et al. Immune-Mediated Effects of Microplanar Radiotherapy with a Small Animal Irradiator. Cancers MDPI AG. 2021;14:155. https:\/\/doi.org\/10.3390\/cancers14010155.","journal-title":"Cancers MDPI AG"},{"key":"8548_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53015-9","author":"P Bergeron","year":"2024","unstructured":"Bergeron P, Dos Santos M, Sitterle L, Tarlet G, Lavigne J, Liu W, et al. Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade. Nat Commun [Internet] Springer Sci Bus Media LLC. 2024. https:\/\/doi.org\/10.1038\/s41467-024-53015-9. [cited 2025 July 10];15.","journal-title":"Nat Commun [Internet] Springer Sci Bus Media LLC"},{"key":"8548_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-024-02514-6","author":"RA Bekker","year":"2024","unstructured":"Bekker RA, Obertopp N, Redler G, Penagaricano J, Caudell JJ, Yamoah K, et al. Spatially fractionated GRID radiation potentiates immune-mediated tumor control. Radiat Oncol [Internet] Springer Sci Bus Media LLC. 2024. https:\/\/doi.org\/10.1186\/s13014-024-02514-6. [cited 2025 July 10];19.","journal-title":"Radiat Oncol [Internet] Springer Sci Bus Media LLC"},{"key":"8548_CR24","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ccell.2023.04.001","volume":"41","author":"M Piper","year":"2023","unstructured":"Piper M, Hoen M, Darragh LB, Knitz MW, Nguyen D, Gadwa J, et al. Simultaneous targeting of PD-1 and IL-2R\u03b2\u03b3 with radiation therapy inhibits pancreatic cancer growth and metastasis. Cancer Cell Elsevier BV. 2023;41:950\u2013e9696. https:\/\/doi.org\/10.1016\/j.ccell.2023.04.001.","journal-title":"Cancer Cell Elsevier BV"},{"key":"8548_CR25","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s43018-025-01018-w","volume":"6","author":"J Huang","year":"2025","unstructured":"Huang J, Theelen WSME, Belcaid Z, Najjar M, van der Geest D, Singh D, et al. Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer. Nat Cancer Nat Publishing Group. 2025;6:1676\u201392. https:\/\/doi.org\/10.1038\/s43018-025-01018-w.","journal-title":"Nat Cancer Nat Publishing Group"},{"key":"8548_CR26","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s12672-025-02914-4","volume":"16","author":"K Xu","year":"2025","unstructured":"Xu K, Gu T, Su K, Liu X, He B, He J, et al. Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma. Discov Onc. 2025;16:1081. https:\/\/doi.org\/10.1007\/s12672-025-02914-4.","journal-title":"Discov Onc"},{"key":"8548_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","volume":"12","author":"FG Herrera","year":"2022","unstructured":"Herrera FG, Ronet C, Ochoa De Olza M, Barras D, Crespo I, Andreatta M, et al. Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy. Cancer Discov. 2022;12:108\u201333. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0003.","journal-title":"Cancer Discov"},{"key":"8548_CR28","doi-asserted-by":"publisher","first-page":"e000537","DOI":"10.1136\/jitc-2020-000537","volume":"8","author":"HB Barsoumian","year":"2020","unstructured":"Barsoumian HB, Ramapriyan R, Younes AI, Caetano MS, Menon H, Comeaux NI, et al. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma. J Immunother Cancer. 2020;8:e000537. https:\/\/doi.org\/10.1136\/jitc-2020-000537.","journal-title":"J Immunother Cancer"},{"key":"8548_CR29","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1158\/0008-5472.CAN-04-0073","volume":"64","author":"M Chakraborty","year":"2004","unstructured":"Chakraborty M, Abrams SI, Coleman CN, Camphausen K, Schlom J, Hodge JW. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res. 2004;64:4328\u201337. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0073.","journal-title":"Cancer Res"},{"key":"8548_CR30","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1158\/1078-0432.ccr-14-2824","volume":"21","author":"A Filatenkov","year":"2015","unstructured":"Filatenkov A, Baker J, Mueller AMS, Kenkel J, Ahn G-O, Dutt S, et al. Ablative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissions. Clin Cancer Res Am Association Cancer Res (AACR). 2015;21:3727\u201339. https:\/\/doi.org\/10.1158\/1078-0432.ccr-14-2824.","journal-title":"Clin Cancer Res Am Association Cancer Res (AACR)"},{"key":"8548_CR31","doi-asserted-by":"publisher","unstructured":"Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, Lord EM. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol. 2005;174:7516\u201323. https:\/\/doi.org\/10.4049\/jimmunol.174.12.7516.","DOI":"10.4049\/jimmunol.174.12.7516"},{"key":"8548_CR32","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.ijrobp.2011.09.049","volume":"83","author":"D Schaue","year":"2012","unstructured":"Schaue D, Ratikan JA, Iwamoto KS, McBride WH. Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys. 2012;83:1306\u201310. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.09.049.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8548_CR33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijrobp.2023.09.014","volume":"118","author":"H Kim","year":"2024","unstructured":"Kim H, Lee E, Cho H, Kim E, Jang WI, Yang K, et al. Five-day spacing of two fractionated ablative radiotherapies enhances antitumor immunity. Int J Radiation Oncol Biology Phys Elsevier. 2024;118:498\u2013511. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.09.014.","journal-title":"Int J Radiation Oncol Biology Phys Elsevier"},{"key":"8548_CR34","doi-asserted-by":"publisher","first-page":"786864","DOI":"10.3389\/fmolb.2022.786864","volume":"9","author":"X Zhao","year":"2022","unstructured":"Zhao X, Li J, Zheng L, Yang Q, Chen X, Chen X, et al. Immune response on optimal timing and fractionation dose for hypofractionated radiotherapy in non-small-cell lung cancer. Front Mol Biosci. 2022;9:786864. https:\/\/doi.org\/10.3389\/fmolb.2022.786864.","journal-title":"Front Mol Biosci"},{"key":"8548_CR35","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1093\/jnci\/djae329","volume":"117","author":"A Buqu\u00e9","year":"2025","unstructured":"Buqu\u00e9 A, Bloy N, Petroni G, Jim\u00e9nez-Cortegana C, Sato A, Iribarren C, et al. Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor\u2013positive mammary carcinogenesis. J Natl Cancer Inst. 2025;117:934\u201347. https:\/\/doi.org\/10.1093\/jnci\/djae329.","journal-title":"J Natl Cancer Inst"},{"key":"8548_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","volume":"14","author":"RR Weichselbaum","year":"2017","unstructured":"Weichselbaum RR, Liang H, Deng L, Fu Y-X. Radiotherapy and immunotherapy: A beneficial liaison? Nat Rev Clin Oncol. 2017;14:365\u201379. https:\/\/doi.org\/10.1038\/nrclinonc.2016.211.","journal-title":"Nat Rev Clin Oncol"},{"key":"8548_CR37","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ijrobp.2020.11.004","volume":"109","author":"S-Y Fu","year":"2021","unstructured":"Fu S-Y, Chen F-H, Wang C-C, Yu C-F, Chiang C-S, Hong J-H. Role of myeloid-derived suppressor cells in high-dose-irradiated TRAMP-C1 tumors: A therapeutic target and an index for assessing tumor microenvironment. Int J Radiation Oncol Biology Phys Elsevier. 2021;109:1547\u201358. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.11.004.","journal-title":"Int J Radiation Oncol Biology Phys Elsevier"},{"key":"8548_CR38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","volume":"54","author":"S Hegde","year":"2021","unstructured":"Hegde S, Leader AM, Merad M. MDSC: Markers, development, states, and unaddressed complexity. Immun Elsevier. 2021;54:875\u201384. https:\/\/doi.org\/10.1016\/j.immuni.2021.04.004.","journal-title":"Immun Elsevier"},{"key":"8548_CR39","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ijrobp.2010.09.034","volume":"81","author":"EL Kachikwu","year":"2011","unstructured":"Kachikwu EL, Iwamoto KS, Liao Y-P, DeMarco JJ, Agazaryan N, Economou JS, et al. Radiation enhances regulatory T cell representation. Int J Radiat Oncol Biol Phys. 2011;81:1128\u201335. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.09.034.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8548_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","volume":"56","author":"S Dikiy","year":"2023","unstructured":"Dikiy S, Rudensky AY. Principles of regulatory T cell function. Immun Elsevier. 2023;56:240\u201355. https:\/\/doi.org\/10.1016\/j.immuni.2023.01.004.","journal-title":"Immun Elsevier"},{"key":"8548_CR41","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ijrobp.2021.05.014","volume":"111","author":"J Sia","year":"2021","unstructured":"Sia J, Hagekyriakou J, Chindris I, Albarakati H, Leong T, Schlenker R, et al. Regulatory T cells shape the differential impact of radiation dose-fractionation schedules on host innate and adaptive antitumor immune defenses. Int J Radiation Oncol Biology Phys Elsevier. 2021;111:502\u201314. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.05.014.","journal-title":"Int J Radiation Oncol Biology Phys Elsevier"},{"key":"8548_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.radonc.2020.05.051","volume":"150","author":"D Chen","year":"2020","unstructured":"Chen D, Patel RR, Verma V, Ramapriyan R, Barsoumian HB, Cortez MA, et al. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy. Radiother Oncol. 2020;150:114\u201320. https:\/\/doi.org\/10.1016\/j.radonc.2020.05.051.","journal-title":"Radiother Oncol"},{"key":"8548_CR43","doi-asserted-by":"publisher","first-page":"100391","DOI":"10.1016\/j.jtocrr.2022.100391","volume":"3","author":"W Jing","year":"2022","unstructured":"Jing W, Xu T, Wu L, Lopez PB, Grassberger C, Ellsworth SG, et al. Severe radiation-induced lymphopenia attenuates the benefit of durvalumab after concurrent chemoradiotherapy for NSCLC. JTO Clin Res Rep. 2022;3:100391. https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100391.","journal-title":"JTO Clin Res Rep"},{"key":"8548_CR44","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1158\/0008-5472.CAN-14-1258","volume":"74","author":"SJ Dovedi","year":"2014","unstructured":"Dovedi SJ, Adlard AL, Lipowska-Bhalla G, McKenna C, Jones S, Cheadle EJ, et al. Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. Cancer Res. 2014;74:5458\u201368. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-1258.","journal-title":"Cancer Res"},{"key":"8548_CR45","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1667\/RR0695.1","volume":"166","author":"MF Jobling","year":"2006","unstructured":"Jobling MF, Mott JD, Finnegan MT, Jurukovski V, Erickson AC, Walian PJ, et al. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Radiat Res. 2006;166:839\u201348. https:\/\/doi.org\/10.1667\/RR0695.1.","journal-title":"Radiat Res"},{"key":"8548_CR46","doi-asserted-by":"publisher","first-page":"6754","DOI":"10.1158\/1078-0432.CCR-11-0544","volume":"17","author":"F Bouquet","year":"2011","unstructured":"Bouquet F, Pal A, Pilones KA, Demaria S, Hann B, Akhurst RJ, et al. TGF\u03b21 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clin Cancer Res. 2011;17:6754\u201365. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0544.","journal-title":"Clin Cancer Res"},{"key":"8548_CR47","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1158\/0008-5472.CAN-14-3511","volume":"75","author":"C Vanpouille-Box","year":"2015","unstructured":"Vanpouille-Box C, Diamond JM, Pilones KA, Zavadil J, Babb JS, Formenti SC, et al. TGF\u03b2 is a master regulator of radiation therapy-induced antitumor immunity. Cancer Res. 2015;75:2232\u201342. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3511.","journal-title":"Cancer Res"},{"key":"8548_CR48","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/s0360-3016(99)00170-4","volume":"45","author":"M Mohiuddin","year":"1999","unstructured":"Mohiuddin M, Fujita M, Regine WF, Megooni AS, Ibbott GS, Ahmed MM. High-dose spatially-fractionated radiation (GRID): A new paradigm in the management of advanced cancers. Int J Radiat Oncol Biol Phys. 1999;45:721\u20137. https:\/\/doi.org\/10.1016\/s0360-3016(99)00170-4.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8548_CR49","doi-asserted-by":"publisher","unstructured":"Wu X, Ahmed MM, Wright J, Gupta S, Pollack A. On modern technical approaches of three-dimensional high-dose lattice radiotherapy (lrt). Cureus [Internet]. 2010 [cited 2025 Apr 14]; https:\/\/doi.org\/10.7759\/cureus.9.","DOI":"10.7759\/cureus.9"},{"key":"8548_CR50","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1073\/pnas.92.19.8783","volume":"92","author":"DN Slatkin","year":"1995","unstructured":"Slatkin DN, Spanne P, Dilmanian FA, Gebbers JO, Laissue JA. Subacute neuropathological effects of microplanar beams of x-rays from a synchrotron wiggler. Proc Natl Acad Sci USA. 1995;92:8783\u20137. https:\/\/doi.org\/10.1073\/pnas.92.19.8783.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8548_CR51","doi-asserted-by":"publisher","unstructured":"Mohiuddin M, Curtis DL, Grizos WT, Komarnicky L. Palliative treatment of advanced cancer using multiple nonconfluent pencil beam radiation. A pilot study. Cancer. 1990;66:114\u20138. https:\/\/doi.org\/10.1002\/1097-0142(19900701)66:1%3C114::aid-cncr2820660121%253E3.0.co;2-l.","DOI":"10.1002\/1097-0142(19900701)66:1%3C114::aid-cncr2820660121%253E3.0.co;2-l"},{"key":"8548_CR52","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.3390\/cancers14163909","volume":"14","author":"G Ferini","year":"2022","unstructured":"Ferini G, Parisi S, Lillo S, Viola A, Minutoli F, Critelli P, et al. Impressive results after metabolism-guided lattice irradiation in patients submitted to palliative radiation therapy: Preliminary results of LATTICE_01 multicenter study. Cancers (Basel). 2022;14:3909. https:\/\/doi.org\/10.3390\/cancers14163909.","journal-title":"Cancers (Basel)"},{"key":"8548_CR53","doi-asserted-by":"publisher","first-page":"7025","DOI":"10.1038\/s41598-020-63975-9","volume":"10","author":"P Lansonneur","year":"2020","unstructured":"Lansonneur P, Mammar H, Nauraye C, Patriarca A, Hierso E, Dendale R, et al. First proton minibeam radiation therapy treatment plan evaluation. Sci Rep. 2020;10:7025. https:\/\/doi.org\/10.1038\/s41598-020-63975-9.","journal-title":"Sci Rep"},{"key":"8548_CR54","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1107\/S0909049509012503","volume":"16","author":"Y Prezado","year":"2009","unstructured":"Prezado Y, Renier M, Bravin A. A new method of creating minibeam patterns for synchrotron radiation therapy: A feasibility study. J Synchrotron Radiat. 2009;16:582\u20136. https:\/\/doi.org\/10.1107\/S0909049509012503.","journal-title":"J Synchrotron Radiat"},{"key":"8548_CR55","doi-asserted-by":"publisher","unstructured":"Laissue JA, Geiser G, Spanne PO, Dilmanian FA, Gebbers JO, Geiser M, et al. Neuropathology of ablation of rat gliosarcomas and contiguous brain tissues using a microplanar beam of synchrotron-wiggler-generated X rays. Int J Cancer. 1998;78(19981123):654\u201360. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19981123)78:5%3C654::aid-ijc21%3E3.0.co;2-l.","DOI":"10.1002\/(sici)1097-0215(19981123)78:5%3C654::aid-ijc21%3E3.0.co;2-l"},{"key":"8548_CR56","doi-asserted-by":"publisher","first-page":"e4637","DOI":"10.7759\/cureus.4637","volume":"11","author":"JI Choi","year":"2019","unstructured":"Choi JI, Daniels J, Cohen D, Li Y, Ha CS, Eng TY. Clinical outcomes of spatially fractionated GRID radiotherapy in the treatment of bulky tumors of the head and neck. Cureus. 2019;11:e4637. https:\/\/doi.org\/10.7759\/cureus.4637.","journal-title":"Cureus"},{"key":"8548_CR57","doi-asserted-by":"publisher","unstructured":"Psarras A, Antanaviciute A, Alase A, Carr I, Wittmann M, Emery P, et al. TNF-\u03b1 regulates human plasmacytoid dendritic cells by suppressing IFN-\u03b1 production and enhancing T cell activation. J Immunol. 2021;206:785\u201396. https:\/\/doi.org\/10.4049\/jimmunol.1901358.","DOI":"10.4049\/jimmunol.1901358"},{"key":"8548_CR58","doi-asserted-by":"publisher","first-page":"20190572","DOI":"10.1259\/bjr.20190572","volume":"93","author":"M Mohiuddin","year":"2020","unstructured":"Mohiuddin M, Lynch C, Gao M, Hartsell W. Early clinical results of proton spatially fractionated GRID radiation therapy (SFGRT). Br J Radiol. 2020;93:20190572. https:\/\/doi.org\/10.1259\/bjr.20190572.","journal-title":"Br J Radiol"},{"key":"8548_CR59","doi-asserted-by":"publisher","unstructured":"Mohiuddin M, Park H, Hallmeyer S, Richards J. High-dose radiation as a dramatic, immunological primer in locally advanced melanoma. Cureus. 2015;7:e417. https:\/\/doi.org\/10.7759\/cureus.417","DOI":"10.7759\/cureus.417"},{"key":"8548_CR60","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1667\/RADE-20-00100.1","volume":"194","author":"JW Snider","year":"2020","unstructured":"Snider JW, Molitoris J, Shyu S, Diwanji T, Rice S, Kowalski E, et al. Spatially fractionated radiotherapy (GRID) prior to standard neoadjuvant conventionally fractionated radiotherapy for bulky, high-risk soft tissue and osteosarcomas: Feasibility, safety, and promising pathologic response rates. Radiat Res. 2020;194:707\u201314. https:\/\/doi.org\/10.1667\/RADE-20-00100.1.","journal-title":"Radiat Res"},{"key":"8548_CR61","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/mp.17634","volume":"52","author":"A Corvino","year":"2025","unstructured":"Corvino A, Schneider T, Vu-Bezin J, Loap P, Kirova Y, Prezado Y. Photon mini-GRID therapy for preoperative breast cancer tumor treatment: A treatment plan study. Med Phys. 2025;52:2493\u2013506. https:\/\/doi.org\/10.1002\/mp.17634.","journal-title":"Med Phys"},{"key":"8548_CR62","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.21873\/anticanres.15968","volume":"42","author":"G Ferini","year":"2022","unstructured":"Ferini G, Valenti V, Viola A, Umana GE, Illari SI, Parisi S, et al. First-ever clinical experience with magnetic resonance-based lattice radiotherapy for treating bulky gynecological tumors. Anticancer Res Int Inst Anticancer Res. 2022;42:4641\u20136. https:\/\/doi.org\/10.21873\/anticanres.15968.","journal-title":"Anticancer Res Int Inst Anticancer Res"},{"key":"8548_CR63","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1667\/RADE-20-00038.1","volume":"194","author":"BE Amendola","year":"2020","unstructured":"Amendola BE, Perez NC, Mayr NA, Wu X, Amendola M. Spatially fractionated radiation therapy using lattice radiation in far-advanced bulky cervical cancer: A clinical and molecular imaging and outcome study. rare. Radiation Res Soc. 2020;194:724\u201336. https:\/\/doi.org\/10.1667\/RADE-20-00038.1.","journal-title":"Radiation Res Soc"},{"key":"8548_CR64","doi-asserted-by":"publisher","first-page":"101566","DOI":"10.1016\/j.adro.2024.101566","volume":"9","author":"G Studer","year":"2024","unstructured":"Studer G, Jeller D, Streller T, Huebner D, Glanzmann C. Time-related outcome following palliative spatially fractionated stereotactic radiation therapy (lattice) of large tumors - a case series. Adv Radiat Oncol. 2024;9:101566. https:\/\/doi.org\/10.1016\/j.adro.2024.101566.","journal-title":"Adv Radiat Oncol"},{"key":"8548_CR65","doi-asserted-by":"publisher","first-page":"101665","DOI":"10.1016\/j.adro.2024.101665","volume":"10","author":"F Iori","year":"2025","unstructured":"Iori F, Trojani V, Zamagni A, Ciammella P, Iori M, Botti A, et al. Spatially fractionated radiation therapy for palliation in patients with large cancers: A retrospective study. Adv Radiat Oncol. 2025;10:101665. https:\/\/doi.org\/10.1016\/j.adro.2024.101665.","journal-title":"Adv Radiat Oncol"},{"key":"8548_CR66","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.radonc.2021.11.023","volume":"167","author":"S Duriseti","year":"2022","unstructured":"Duriseti S, Kavanaugh JA, Szymanski J, Huang Y, Basarabescu F, Chaudhuri A, et al. LITE SABR M1: A phase I trial of lattice stereotactic body radiotherapy for large tumors. Radiother Oncol. 2022;167:317\u201322. https:\/\/doi.org\/10.1016\/j.radonc.2021.11.023.","journal-title":"Radiother Oncol"},{"key":"8548_CR67","doi-asserted-by":"publisher","first-page":"101401","DOI":"10.1016\/j.adro.2023.101401","volume":"9","author":"SK Ahmed","year":"2024","unstructured":"Ahmed SK, Petersen IA, Grams MP, Finley RR, Haddock MG, Owen D. Spatially fractionated radiation therapy in sarcomas: A large single-institution experience. Adv Radiation Oncol. 2024;9:101401. https:\/\/doi.org\/10.1016\/j.adro.2023.101401.","journal-title":"Adv Radiation Oncol"},{"key":"8548_CR68","doi-asserted-by":"publisher","unstructured":"Majercakova K, Aguilar NT, Verdum JI, Bargall\u00f3 HV, Capel AV, Soto MM, et al. Role of spatially fractionated radiotherapy (LATTICE) treatment in inoperable bulky soft-tissue sarcomas. Cancers [Internet]. 2025. [cited 2026 Mar 10];17. https:\/\/doi.org\/10.3390\/cancers17040624.","DOI":"10.3390\/cancers17040624"},{"key":"8548_CR69","doi-asserted-by":"publisher","unstructured":"Studer G, Streller T, Jeller D, Huebner D, Fuchs B, Glanzmann C. Diagnosis-related outcome following palliative spatially fractionated radiation therapy (lattice) of large tumors. Cancers [Internet]. 2025. [cited 2026 Mar 10];17. https:\/\/doi.org\/10.3390\/cancers17172752.","DOI":"10.3390\/cancers17172752"},{"key":"8548_CR70","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ijrobp.2024.06.035","volume":"120","author":"MP Grams","year":"2024","unstructured":"Grams MP, Mateus CQ, Mashayekhi M, Mutter RW, Djonov V, Fazzari JM, et al. Minibeam radiation therapy treatment (MBRT): Commissioning and first clinical implementation. Int J Radiation Oncol Biology Phys Elsevier. 2024;120:1423\u201334. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.06.035.","journal-title":"Int J Radiation Oncol Biology Phys Elsevier"},{"key":"8548_CR71","doi-asserted-by":"publisher","unstructured":"Jacobson MA, Sharifzadeh Y, Dudek AZ, Markovic SN, Johnson JE, Morris JM, et al. Minibeam radiation therapy for recurrent mucosal melanoma: an eye-opening response. Mayo Clin Proc Innov Qual Outcomes. 2025;9:100640. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2025.100640.","DOI":"10.1016\/j.mayocpiqo.2025.100640"},{"key":"8548_CR72","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/cancers14030685","volume":"14","author":"KM Kraus","year":"2022","unstructured":"Kraus KM, Winter J, Zhang Y, Ahmed M, Combs SE, Wilkens JJ, et al. Treatment planning study for microbeam radiotherapy using clinical patient data. Cancers (Basel). 2022;14:685. https:\/\/doi.org\/10.3390\/cancers14030685.","journal-title":"Cancers (Basel)"},{"key":"8548_CR73","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.ijrobp.2022.04.022","volume":"113","author":"J-F Adam","year":"2022","unstructured":"Adam J-F, Balosso J, Bayat S, Berkvens P, Berruyer G, Br\u00e4uer-Krisch E, et al. Toward neuro-oncologic clinical trials of high-dose-rate synchrotron microbeam radiation therapy: First treatment of a spontaneous canine brain tumor. Int J Radiation Oncol Biology Phys Elsevier. 2022;113:967\u201373. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.04.022.","journal-title":"Int J Radiation Oncol Biology Phys Elsevier"},{"key":"8548_CR74","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3390\/cancers14061545","volume":"14","author":"H Scherthan","year":"2022","unstructured":"Scherthan H, Wagner S-Q, Grundh\u00f6fer J, Matejka N, M\u00fcller J, M\u00fcller S, et al. Planar proton minibeam irradiation elicits spatially confined DNA damage in a human epidermis model. Cancers (Basel). 2022;14:1545. https:\/\/doi.org\/10.3390\/cancers14061545.","journal-title":"Cancers (Basel)"},{"key":"8548_CR75","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41590-019-0561-4","volume":"21","author":"ME Rodriguez-Ruiz","year":"2020","unstructured":"Rodriguez-Ruiz ME, Vitale I, Harrington KJ, Melero I, Galluzzi L. Immunological impact of cell death signaling driven by radiation on the tumor microenvironment. Nat Immunol. 2020;21:120\u201334. https:\/\/doi.org\/10.1038\/s41590-019-0561-4.","journal-title":"Nat Immunol"},{"key":"8548_CR76","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm1622","volume":"13","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4\u2013dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13:1050\u20139. https:\/\/doi.org\/10.1038\/nm1622.","journal-title":"Nat Med"},{"key":"8548_CR77","doi-asserted-by":"publisher","first-page":"15618","DOI":"10.1038\/ncomms15618","volume":"8","author":"C Vanpouille-Box","year":"2017","unstructured":"Vanpouille-Box C, Alard A, Aryankalayil MJ, Sarfraz Y, Diamond JM, Schneider RJ, et al. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nat Commun. 2017;8:15618. https:\/\/doi.org\/10.1038\/ncomms15618.","journal-title":"Nat Commun"},{"key":"8548_CR78","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","volume":"24","author":"F Klug","year":"2013","unstructured":"Klug F, Prakash H, Huber PE, Seibel T, Bender N, Halama N, et al. Low-dose irradiation programs macrophage differentiation to an iNOS+\/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell. 2013;24:589\u2013602. https:\/\/doi.org\/10.1016\/j.ccr.2013.09.014.","journal-title":"Cancer Cell"},{"key":"8548_CR79","doi-asserted-by":"publisher","first-page":"e0229053","DOI":"10.1371\/journal.pone.0229053","volume":"15","author":"JN Rivera","year":"2020","unstructured":"Rivera JN, Kierski TM, Kasoji SK, Abrantes AS, Dayton PA, Chang SX. Conventional dose rate spatially-fractionated radiation therapy (SFRT) treatment response and its association with dosimetric parameters-a preclinical study in a fischer 344 rat model. PLoS ONE. 2020;15:e0229053. https:\/\/doi.org\/10.1371\/journal.pone.0229053.","journal-title":"PLoS ONE"},{"key":"8548_CR80","doi-asserted-by":"publisher","unstructured":"Potiron S, Iturri L, Juchaux M, Espenon J, Gilbert C, McGarrigle J et al. The significance of dose heterogeneity on the anti-tumor response of minibeam radiation therapy. Radiotherapy and Oncology [Internet]. 2024 [cited 2025 Sept 17];201. https:\/\/doi.org\/10.1016\/j.radonc.2024.110577","DOI":"10.1016\/j.radonc.2024.110577"},{"key":"8548_CR81","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ijrobp.2018.10.009","volume":"103","author":"E Markovsky","year":"2019","unstructured":"Markovsky E, Budhu S, Samstein RM, Li H, Russell J, Zhang Z, et al. An antitumor immune response is evoked by partial-volume single-dose radiation in 2 murine models. Int J Radiat Oncol Biol Phys. 2019;103:697\u2013708. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.10.009.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"8548_CR82","doi-asserted-by":"publisher","unstructured":"Smyth LML, Crosbie JC, Sloggett C, Rogers PAW, Donoghue JF. Spatially fractionated X-ray microbeams elicit a more sustained immune and inflammatory response in the brainstem than homogenous irradiation. Radiation Res [Internet]. 2021 [cited 2025 Mar 19];196. https:\/\/doi.org\/10.1667\/RADE-20-00082.1.","DOI":"10.1667\/RADE-20-00082.1"},{"key":"8548_CR83","doi-asserted-by":"publisher","first-page":"e81874","DOI":"10.1371\/journal.pone.0081874","volume":"8","author":"A Bouchet","year":"2013","unstructured":"Bouchet A, Sakakini N, El Atifi M, Le Clec\u2019h C, Brauer E, Moisan A et al. F <>Mattei editor 2013 Early gene expression analysis in 9L orthotopic tumor-bearing rats identifies immune modulation in molecular response to synchrotron microbeam radiation therapy. PLoS ONE 8 e81874 https:\/\/doi.org\/10.1371\/journal.pone.0081874.","journal-title":"PLoS ONE"},{"key":"8548_CR84","doi-asserted-by":"publisher","unstructured":"Bouchet A, Brauer-Krisch E, Prezado Y, El Atifi M, Rogalev L, Le Clec\u2019h C, et al. Better efficacy of synchrotron spatially microfractionated radiation therapy than uniform radiation therapy on glioma. Int J Radiat Oncol Biol Phys. 2016;95:1485\u201394. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.03.040.","DOI":"10.1016\/j.ijrobp.2016.03.040"},{"key":"8548_CR85","doi-asserted-by":"publisher","unstructured":"Potez M, Fernandez-Palomo C, Bouchet A, Trappetti V, Donzelli M, Krisch M, et al. Synchrotron microbeam radiation therapy as a new approach for the treatment of radioresistant melanoma: Potential underlying mechanisms. Int J Radiat Oncol Biol Phys. 2019;105:1126\u201336. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.08.027.","DOI":"10.1016\/j.ijrobp.2019.08.027"},{"key":"8548_CR86","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.radonc.2019.01.006","volume":"133","author":"Y Yang","year":"2019","unstructured":"Yang Y, Swierczak A, Ibahim M, Paiva P, Cann L, Stevenson AW, et al. Synchrotron microbeam radiotherapy evokes a different early tumor immunomodulatory response to conventional radiotherapy in EMT6.5 mammary tumors. Radiother Oncol. 2019;133:93\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2019.01.006.","journal-title":"Radiother Oncol"},{"key":"8548_CR87","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1667\/RR13778.1","volume":"182","author":"Y Yang","year":"2014","unstructured":"Yang Y, Crosbie JC, Paiva P, Ibahim M, Stevenson A, Rogers PAW. In vitro study of genes and molecular pathways differentially regulated by synchrotron microbeam radiotherapy. Radiat Res Lawrence: Radiation Res Soc. 2014;182:626\u201339. https:\/\/doi.org\/10.1667\/RR13778.1.","journal-title":"Radiat Res Lawrence: Radiation Res Soc"},{"key":"8548_CR88","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-020-01165-x","volume":"19","author":"H Yang","year":"2020","unstructured":"Yang H, Zhang Q, Xu M, Wang L, Chen X, Feng Y, et al. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol Cancer. 2020;19:41. https:\/\/doi.org\/10.1186\/s12943-020-01165-x.","journal-title":"Mol Cancer"},{"key":"8548_CR89","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/iid3.523","volume":"9","author":"H Gu","year":"2021","unstructured":"Gu H, Deng W, Zheng Z, Wu K, Sun F. CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid-derived suppressor cells. Immun Inflamm Dis. 2021;9:1686\u201395. https:\/\/doi.org\/10.1002\/iid3.523.","journal-title":"Immun Inflamm Dis"},{"key":"8548_CR90","doi-asserted-by":"publisher","first-page":"972383","DOI":"10.3389\/fonc.2022.972383","volume":"12","author":"J Qiu","year":"2022","unstructured":"Qiu J, Xu L, Zeng X, Wu H, Liang F, Lv Q, et al. CCL5 mediates breast cancer metastasis and prognosis through CCR5\/treg cells. Front Oncol. 2022;12:972383. https:\/\/doi.org\/10.3389\/fonc.2022.972383.","journal-title":"Front Oncol"},{"key":"8548_CR91","doi-asserted-by":"publisher","first-page":"1814620","DOI":"10.1080\/2162402X.2020.1814620","volume":"9","author":"H Mashima","year":"2020","unstructured":"Mashima H, Zhang R, Kobayashi T, Hagiya Y, Tsukamoto H, Liu T, et al. Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response. Oncoimmunology. 2020;9:1814620. https:\/\/doi.org\/10.1080\/2162402X.2020.1814620.","journal-title":"Oncoimmunology"},{"key":"8548_CR92","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.exphem.2007.05.001","volume":"35","author":"EA Eksioglu","year":"2007","unstructured":"Eksioglu EA, Mahmood SS, Chang M, Reddy V. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory responseGM-CSF. Exp Hematol. 2007;35:1163\u201371. https:\/\/doi.org\/10.1016\/j.exphem.2007.05.001.","journal-title":"Exp Hematol"},{"key":"8548_CR93","doi-asserted-by":"publisher","first-page":"E9271","DOI":"10.1073\/pnas.1703921114","volume":"114","author":"T Mgrditchian","year":"2017","unstructured":"Mgrditchian T, Arakelian T, Paggetti J, Noman MZ, Viry E, Moussay E, et al. Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner. Proc Natl Acad Sci U S A. 2017;114:E9271\u20139. https:\/\/doi.org\/10.1073\/pnas.1703921114.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8548_CR94","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1158\/0008-5472.CAN-17-1066","volume":"77","author":"J Ventura","year":"2017","unstructured":"Ventura J, Lobachevsky PN, Palazzolo JS, Forrester H, Haynes NM, Ivashkevich A, et al. Localized synchrotron irradiation of mouse skin induces persistent systemic genotoxic and immune responses. Cancer Res Philadelphia: Amer Assoc Cancer Res. 2017;77:6389\u201399. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1066.","journal-title":"Cancer Res Philadelphia: Amer Assoc Cancer Res"},{"key":"8548_CR95","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1667\/RR2885.1","volume":"178","author":"CN Sprung","year":"2012","unstructured":"Sprung CN, Yang Y, Forrester HB, Li J, Zaitseva M, Cann L, et al. Genome-wide transcription responses to synchrotron microbeam radiotherapy. Radiat Res. 2012;178:249. https:\/\/doi.org\/10.1667\/RR2885.1.","journal-title":"Radiat Res"},{"key":"8548_CR96","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1667\/RR14115.1","volume":"185","author":"MJ Ibahim","year":"2016","unstructured":"Ibahim MJ, Yang Y, Crosbie JC, Stevenson A, Cann L, Paiva P, et al. Eosinophil-associated gene pathways but not eosinophil numbers are differentially regulated between synchrotron microbeam radiation treatment and synchrotron broad-beam treatment by 48 hours postirradiation. Radiat Res. 2016;185:60\u20138. https:\/\/doi.org\/10.1667\/RR14115.1.","journal-title":"Radiat Res"},{"key":"8548_CR97","doi-asserted-by":"publisher","unstructured":"Johnsrud AJ, Jenkins SV, Jamshidi-Parsian A, Quick CM, Galhardo EP, Dings RPM et al. Evidence for early stage anti-tumor immunity elicited by spatially fractionated radiotherapy-immunotherapy combinations. Radiation Res [Internet]. 2020 [cited 2025 June 11];194. https:\/\/doi.org\/10.1667\/RADE-20-00065.1.","DOI":"10.1667\/RADE-20-00065.1"},{"key":"8548_CR98","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41419-025-07471-w","volume":"16","author":"P Fan","year":"2025","unstructured":"Fan P, Qi Z, Liu Z, Wang S, Wang Y, Kuai J, et al. High baseline levels of PD-L1 reduce the heterogeneity of immune checkpoint signature and sensitize anti-PD1 therapy in lung and colorectal cancers. Cell Death Dis Nat Publishing Group. 2025;16:152. https:\/\/doi.org\/10.1038\/s41419-025-07471-w.","journal-title":"Cell Death Dis Nat Publishing Group"},{"key":"8548_CR99","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1158\/2326-6066.CIR-24-0902","volume":"13","author":"L Iturri","year":"2025","unstructured":"Iturri L, Riquelme-Perez M, Bont\u00e9 P-E, Potiron S, Goudot C, Juchaux M, et al. Evaluation of proton minibeam radiotherapy on antitumor immune responses in a rat model of glioblastoma. Cancer Immunol Res. 2025;13:1854\u201372. https:\/\/doi.org\/10.1158\/2326-6066.CIR-24-0902.","journal-title":"Cancer Immunol Res"},{"key":"8548_CR100","doi-asserted-by":"publisher","first-page":"16073","DOI":"10.1038\/ncomms16073","volume":"8","author":"M Enamorado","year":"2017","unstructured":"Enamorado M, Iborra S, Priego E, Cueto FJ, Quintana JA, Mart\u00ednez-Cano S, et al. Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8\u2009+\u2009T cells. Nat Commun. 2017;8:16073. https:\/\/doi.org\/10.1038\/ncomms16073.","journal-title":"Nat Commun"},{"key":"8548_CR101","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.imlet.2014.10.011","volume":"162","author":"JMM den Haan","year":"2014","unstructured":"den Haan JMM, Arens R, van Zelm MC. The activation of the adaptive immune system: Cross-talk between antigen-presenting cells, T cells and B cells. Immunol Lett. 2014;162:103\u201312. https:\/\/doi.org\/10.1016\/j.imlet.2014.10.011.","journal-title":"Immunol Lett"},{"key":"8548_CR102","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard C, Larriv\u00e9e B. Tumor angiogenesis and vascular normalization: Alternative therapeutic targets. Angiogenesis. 2017;20:409\u201326. https:\/\/doi.org\/10.1007\/s10456-017-9562-9.","journal-title":"Angiogenesis"},{"key":"8548_CR103","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"Z-L Liu","year":"2023","unstructured":"Liu Z-L, Chen H-H, Zheng L-L, Sun L-P, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023;8:198. https:\/\/doi.org\/10.1038\/s41392-023-01460-1.","journal-title":"Signal Transduct Target Ther"},{"key":"8548_CR104","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","volume":"91","author":"S Goel","year":"2011","unstructured":"Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 2011;91:1071\u2013121. https:\/\/doi.org\/10.1152\/physrev.00038.2010.","journal-title":"Physiol Rev"},{"key":"8548_CR105","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12967-025-06273-0","volume":"23","author":"H Huang","year":"2025","unstructured":"Huang H, Xu Y, Guo Z, Zhang M, Li W, Song Y, et al. Irradiation-responsive PRDM10-DT modulates the angiogenic response in human NSCLC cells in an SP1-dependent manner via the miR-663a\/TGF-\u03b21 axis. J Transl Med. 2025;23:235. https:\/\/doi.org\/10.1186\/s12967-025-06273-0.","journal-title":"J Transl Med"},{"key":"8548_CR106","first-page":"2413","volume":"61","author":"L Geng","year":"2001","unstructured":"Geng L, Donnelly E, McMahon G, Lin PC, Sierra-Rivera E, Oshinka H, et al. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res. 2001;61:2413\u20139.","journal-title":"Cancer Res"},{"key":"8548_CR107","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1667\/RR2200.1","volume":"175","author":"S Vincenti","year":"2011","unstructured":"Vincenti S, Brillante N, Lanza V, Bozzoni I, Presutti C, Chiani F, et al. HUVEC respond to radiation by inducing the expression of pro-angiogenic microRNAs. Radiat Res. 2011;175:535\u201346. https:\/\/doi.org\/10.1667\/RR2200.1.","journal-title":"Radiat Res"},{"key":"8548_CR108","doi-asserted-by":"publisher","first-page":"e11222","DOI":"10.1371\/journal.pone.0011222","volume":"5","author":"I Sofia Vala","year":"2010","unstructured":"Sofia Vala I, Martins LR, Imaizumi N, Nunes RJ, Rino J, Kuonen F, et al. Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PLoS ONE. 2010;5:e11222. https:\/\/doi.org\/10.1371\/journal.pone.0011222.","journal-title":"PLoS ONE"},{"key":"8548_CR109","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ijrobp.2008.06.1925","volume":"72","author":"TD Solberg","year":"2008","unstructured":"Solberg TD, Nearman J, Mullins J, Li S, Baranowska-Kortylewicz J. Correlation between tumor growth delay and expression of cancer and host VEGF, VEGFR2, and osteopontin in response to radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:918\u201326. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.06.1925.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8548_CR110","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ijrobp.2016.01.064","volume":"95","author":"C Song","year":"2016","unstructured":"Song C, Hong B-J, Bok S, Lee C-J, Kim Y-E, Jeon S-R, et al. Real-time tumor oxygenation changes after single high-dose radiation therapy in orthotopic and subcutaneous lung cancer in mice: Clinical implication for stereotactic ablative radiation therapy schedule optimization. Int J Radiat Oncol Biol Phys. 2016;95:1022\u201331. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.01.064.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8548_CR111","doi-asserted-by":"publisher","unstructured":"Bouchet A, Lemasson B, Le Duc G, Maisin C, Brauer-Krisch E, Siegbahn EA, et al. Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9l gliosarcoma vascular networks. Int J Radiat Oncol Biol Phys. 2010;78:1503\u201312. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.06.021.","DOI":"10.1016\/j.ijrobp.2010.06.021"},{"key":"8548_CR112","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0002-9440(10)64920-6","volume":"160","author":"S Morikawa","year":"2002","unstructured":"Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol. 2002;160:985\u20131000. https:\/\/doi.org\/10.1016\/S0002-9440(10)64920-6.","journal-title":"Am J Pathol"},{"key":"8548_CR113","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/S0002-9440(10)63540-7","volume":"163","author":"P Baluk","year":"2003","unstructured":"Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol. 2003;163:1801\u201315. https:\/\/doi.org\/10.1016\/S0002-9440(10)63540-7.","journal-title":"Am J Pathol"},{"key":"8548_CR114","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5114\/pjp.2016.59477","volume":"67","author":"O Ferician","year":"2016","unstructured":"Ferician O, Cimpean AM, Ceausu AR, Dema A, Raica M, Cumpanas A. Heterogeneous vascular patterns in renal cell carcinomas. Pol J Pathol. 2016;67:46\u201353. https:\/\/doi.org\/10.5114\/pjp.2016.59477.","journal-title":"Pol J Pathol"},{"key":"8548_CR115","first-page":"49","volume":"46","author":"M Frontczak-Baniewicz","year":"2008","unstructured":"Frontczak-Baniewicz M, Czajkowska D, Andrychowski J, Walski M. The immature endothelial cell in human glioma. Ultrastructural features of blood capillary vessels. Folia Neuropathol. 2008;46:49\u201356.","journal-title":"Folia Neuropathol"},{"key":"8548_CR116","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.radonc.2013.05.013","volume":"108","author":"A Bouchet","year":"2013","unstructured":"Bouchet A, Lemasson B, Christen T, Potez M, Rome C, Coquery N, et al. Synchrotron microbeam radiation therapy induces hypoxia in intracerebral gliosarcoma but not in the normal brain. Radiother Oncol. 2013;108:143\u20138. https:\/\/doi.org\/10.1016\/j.radonc.2013.05.013.","journal-title":"Radiother Oncol"},{"key":"8548_CR117","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.ijrobp.2017.03.025","volume":"98","author":"A Bouchet","year":"2017","unstructured":"Bouchet A, Potez M, Coquery N, Rome C, Lemasson B, Br\u00e4uer-Krisch E, et al. Permeability of brain tumor vessels induced by uniform or spatially microfractionated synchrotron radiation therapies. Int J Radiation Oncology*Biology*Physics. 2017;98:1174\u201382. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.025.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"8548_CR118","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science. 2005;307:58\u201362. https:\/\/doi.org\/10.1126\/science.1104819.","journal-title":"Science"},{"key":"8548_CR119","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1667\/RR2784.1","volume":"177","author":"RJ Griffin","year":"2012","unstructured":"Griffin RJ, Koonce NA, Dings RPM, Siegel E, Moros EG, Br\u00e4uer-Krisch E, et al. Microbeam radiation therapy alters vascular architecture and tumor oxygenation and is enhanced by a galectin-1 targeted anti-angiogenic peptide. Radiat Res. 2012;177:804\u201312. https:\/\/doi.org\/10.1667\/RR2784.1.","journal-title":"Radiat Res"},{"key":"8548_CR120","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/09553002.2020.1807642","volume":"97","author":"R Jia","year":"2021","unstructured":"Jia R, Chen Y, Jia C, Hu B, Du Y. Suppression of innate immune signaling molecule, MAVS, reduces radiation-induced bystander effect. Int J Radiat Biol. 2021;97:102\u201310. https:\/\/doi.org\/10.1080\/09553002.2020.1807642.","journal-title":"Int J Radiat Biol"},{"key":"8548_CR121","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13014-019-1227-y","volume":"14","author":"S Tubin","year":"2019","unstructured":"Tubin S, Popper HH, Brcic L. Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): Improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects. Radiat Oncol. 2019;14:21. https:\/\/doi.org\/10.1186\/s13014-019-1227-y.","journal-title":"Radiat Oncol"},{"key":"8548_CR122","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1667\/RR2780.1","volume":"177","author":"RS Asur","year":"2012","unstructured":"Asur RS, Sharma S, Chang C-W, Penagaricano J, Kommuru IM, Moros EG, et al. Spatially fractionated radiation induces cytotoxicity and changes in gene expression in bystander and radiation adjacent murine carcinoma cells. rare. Radiation Res Soc. 2012;177:751\u201365. https:\/\/doi.org\/10.1667\/RR2780.1.","journal-title":"Radiation Res Soc"},{"key":"8548_CR123","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1667\/RR13712.1","volume":"183","author":"AN Fontanella","year":"2015","unstructured":"Fontanella AN, Boss M-K, Hadsell M, Zhang J, Schroeder T, Berman KG, et al. Effects of high-dose microbeam irradiation on tumor microvascular function and angiogenesis. Radiat Res. 2015;183:147. https:\/\/doi.org\/10.1667\/RR13712.1.","journal-title":"Radiat Res"},{"key":"8548_CR124","doi-asserted-by":"publisher","first-page":"e0119924","DOI":"10.1371\/journal.pone.0119924","volume":"10","author":"C Fernandez-Palomo","year":"2015","unstructured":"Fernandez-Palomo C, Mothersill C, Br\u00e4uer-Krisch E, Laissue J, Seymour C, Sch\u00fcltke E. \u03b3-H2AX as a marker for dose deposition in the brain of wistar rats after synchrotron microbeam radiation. PLoS ONE. 2015;10:e0119924. https:\/\/doi.org\/10.1371\/journal.pone.0119924.","journal-title":"PLoS ONE"},{"key":"8548_CR125","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1080\/09553002.2020.1834163","volume":"96","author":"F Pakniyat","year":"2020","unstructured":"Pakniyat F, Nedaie HA, Mozdarani H, Mahmoudzadeh A, Salimi M, Griffin RJ, et al. Enhanced response of radioresistant carcinoma cell line to heterogeneous dose distribution of grid; the role of high-dose bystander effect. Int J Radiat Biol. 2020;96:1585\u201396. https:\/\/doi.org\/10.1080\/09553002.2020.1834163.","journal-title":"Int J Radiat Biol"},{"key":"8548_CR126","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lssr.2015.06.004","volume":"6","author":"M Tomita","year":"2015","unstructured":"Tomita M, Matsumoto H, Funayama T, Yokota Y, Otsuka K, Maeda M, et al. Nitric oxide-mediated bystander signal transduction induced by heavy-ion microbeam irradiation. Life Sci Space Res (Amst). 2015;6:36\u201343. https:\/\/doi.org\/10.1016\/j.lssr.2015.06.004.","journal-title":"Life Sci Space Res (Amst)"},{"key":"8548_CR127","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1073\/pnas.98.2.473","volume":"98","author":"EI Azzam","year":"2001","unstructured":"Azzam EI, De Toledo SM, Little JB. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from \u03b1-particle irradiated to nonirradiated cells. Proc Natl Acad Sci USA. 2001;98:473\u20138. https:\/\/doi.org\/10.1073\/pnas.98.2.473.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8548_CR128","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.ijrobp.2010.11.034","volume":"79","author":"KT Butterworth","year":"2011","unstructured":"Butterworth KT, McGarry CK, Trainor C, O\u2019Sullivan JM, Hounsell AR, Prise KM. Out-of-field cell survival following exposure to intensity-modulated radiation fields. Int J Radiation Oncology*Biology*Physics. 2011;79:1516\u201322. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.11.034.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"8548_CR129","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2307\/3579958","volume":"149","author":"C Mothersill","year":"1998","unstructured":"Mothersill C, Seymour CB. Cell-cell contact during gamma irradiation is not required to induce a bystander effect in normal human keratinocytes: Evidence for release during irradiation of a signal controlling survival into the medium. Radiation Res Radiation Res Soc. 1998;149:256\u201362. https:\/\/doi.org\/10.2307\/3579958.","journal-title":"Radiation Res Radiation Res Soc"},{"key":"8548_CR130","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1667\/RR0864.1","volume":"168","author":"H Yang","year":"2007","unstructured":"Yang H, Anzenberg V, Held KD. The time dependence of bystander responses induced by iron-ion radiation in normal human skin fibroblasts. Radiat Res. 2007;168:292\u20138. https:\/\/doi.org\/10.1667\/RR0864.1.","journal-title":"Radiat Res"},{"key":"8548_CR131","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.4161\/rna.34380","volume":"11","author":"S Xu","year":"2014","unstructured":"Xu S, Ding N, Pei H, Hu W, Wei W, Zhang X, et al. MiR-21 is involved in radiation-induced bystander effects. RNA Biology Informa UK Ltd. 2014;11:1161\u201370. https:\/\/doi.org\/10.4161\/rna.34380.","journal-title":"RNA Biology Informa UK Ltd"},{"key":"8548_CR132","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.7150\/thno.101922","volume":"14","author":"M Yang","year":"2024","unstructured":"Yang M, Wang L, Qin S, Dai X, Li J, An L, et al. Role of damaged mitochondrial transfer in alpha-particle generator212 pb radiation-induced bystander effect. Theranostics. 2024;14:6768\u201382. https:\/\/doi.org\/10.7150\/thno.101922.","journal-title":"Theranostics"},{"key":"8548_CR133","first-page":"1990","volume":"63","author":"K Camphausen","year":"2003","unstructured":"Camphausen K, Moses MA, M\u00e9nard C, Sproull M, Beecken W-D, Folkman J, et al. Radiation abscopal antitumor effect is mediated through p53. Cancer Res. 2003;63:1990\u20133.","journal-title":"Cancer Res"},{"key":"8548_CR134","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1148\/93.2.410","volume":"93","author":"MP Nobler","year":"1969","unstructured":"Nobler MP. The abscopal effect in malignant lymphoma and its relationship to lymphocyte circulation. Radiology. 1969;93:410\u20132. https:\/\/doi.org\/10.1148\/93.2.410.","journal-title":"Radiology"},{"key":"8548_CR135","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1259\/0007-1285-46-543-220","volume":"46","author":"G Ehlers","year":"1973","unstructured":"Ehlers G, Fridman M. Abscopal effect of radiation in papillary adenocarcinoma. BJR. 1973;46:220\u20132. https:\/\/doi.org\/10.1259\/0007-1285-46-543-220.","journal-title":"BJR"},{"key":"8548_CR136","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0009-9260(81)80310-8","volume":"32","author":"GJG Rees","year":"1981","unstructured":"Rees GJG. Abscopal regression in lymphoma: A mechanism in common with total body irradiation? Clin Radiol. 1981;32:475\u201380. https:\/\/doi.org\/10.1016\/S0009-9260(81)80310-8.","journal-title":"Clin Radiol"},{"key":"8548_CR137","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1259\/0007-1285-56-661-63","volume":"56","author":"GJG Rees","year":"1983","unstructured":"Rees GJG, Ross CMD. Abscopal regression following radiotherapy for adenocarcinoma. BJR. 1983;56:63\u20136. https:\/\/doi.org\/10.1259\/0007-1285-56-661-63.","journal-title":"BJR"},{"key":"8548_CR138","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/gut.43.4.575","volume":"43","author":"K Ohba","year":"1998","unstructured":"Ohba K, Omagari K, Nakamura T, Ikuno N, Saeki S, Matsuo I, et al. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut. 1998;43:575\u20137. https:\/\/doi.org\/10.1136\/gut.43.4.575.","journal-title":"Gut"},{"key":"8548_CR139","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0360-3016(77)90020-7","volume":"2","author":"J Antoniades","year":"1977","unstructured":"Antoniades J, Brady LW, Lightfoot DA. Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas. Int J Radiation Oncol Biology Phys Elsevier. 1977;2:141\u20137. https:\/\/doi.org\/10.1016\/0360-3016(77)90020-7.","journal-title":"Int J Radiation Oncol Biology Phys Elsevier"},{"key":"8548_CR140","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s43018-022-00456-0","volume":"3","author":"Y Nishiga","year":"2022","unstructured":"Nishiga Y, Drainas AP, Baron M, Bhattacharya D, Barkal AA, Ahrari Y, et al. Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect. Nat Cancer. 2022;3:1351\u201366. https:\/\/doi.org\/10.1038\/s43018-022-00456-0.","journal-title":"Nat Cancer"},{"key":"8548_CR141","doi-asserted-by":"publisher","first-page":"165010","DOI":"10.1088\/1361-6560\/ace819","volume":"68","author":"Y-B Cho","year":"2023","unstructured":"Cho Y-B, Yoon N, Suh JH, Scott JG. Radio-immune response modelling for spatially fractionated radiotherapy. Phys Med Biol. 2023;68:165010. https:\/\/doi.org\/10.1088\/1361-6560\/ace819.","journal-title":"Phys Med Biol"},{"key":"8548_CR142","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","volume":"15","author":"MZ Dewan","year":"2009","unstructured":"Dewan MZ, Galloway AE, Kawashima N, Dewyngaert JK, Babb JS, Formenti SC, et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti\u2013CTLA-4 antibody. Clin Cancer Res. 2009;15:5379\u201388. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0265.","journal-title":"Clin Cancer Res"},{"key":"8548_CR143","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/HP.0000000000000525","volume":"111","author":"C Fernandez-Palomo","year":"2016","unstructured":"Fernandez-Palomo C, Sch\u00fcltke E, Br\u00e4uer-Krisch E, Laissue JA, Blattmann H, Seymour C, et al. Investigation of abscopal and bystander effects in immunocompromised mice after exposure to pencilbeam and microbeam synchrotron radiation. Health Phys. 2016;111:149\u201359. https:\/\/doi.org\/10.1097\/HP.0000000000000525.","journal-title":"Health Phys"},{"key":"8548_CR144","doi-asserted-by":"publisher","unstructured":"Lobachevsky PN, Ventura J, Giannakandropoulou L, Forrester H, Palazzolo JS, Haynes NM, et al. A functional immune system is required for the systemic genotoxic effects of localized irradiation. Int J Radiat Oncol Biol Phys. 2019;103:1184\u201393. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.11.066.","DOI":"10.1016\/j.ijrobp.2018.11.066"},{"key":"8548_CR145","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/radiation5010003","volume":"5","author":"JN Rivera","year":"2025","unstructured":"Rivera JN, Laemont K, Tovmasyan A, Stryker S, Young K, Charity T, et al. Minibeam spatially-fractionated radiation therapy is superior to uniform dose radiation therapy for abscopal effect when combined with PD-L1 checkpoint inhibitor immunotherapy in a dual tumor murine mammary carcinoma model. Radiation Multidisciplinary Digit Publishing Inst. 2025;5:3. https:\/\/doi.org\/10.3390\/radiation5010003.","journal-title":"Radiation Multidisciplinary Digit Publishing Inst"},{"key":"8548_CR146","doi-asserted-by":"publisher","first-page":"100911","DOI":"10.1016\/j.ctro.2025.100911","volume":"51","author":"L Iturri","year":"2025","unstructured":"Iturri L, Jouglar E, Gilbert C, Espenon J, Juchaux M, Prezado Y. A first evaluation of the efficacy of minibeam radiation therapy combined with an immune check point inhibitor in a model of glioma-bearing rats. Clin Translational Radiation Oncol. 2025;51:100911. https:\/\/doi.org\/10.1016\/j.ctro.2025.100911.","journal-title":"Clin Translational Radiation Oncol"},{"key":"8548_CR147","doi-asserted-by":"publisher","first-page":"217326","DOI":"10.1016\/j.canlet.2024.217326","volume":"608","author":"V Trappetti","year":"2025","unstructured":"Trappetti V, Fern\u00e1ndez-Palomo C, Arora P, Potez M, Pellicioli P, Fazzari J, et al. Towards melanoma in situ vaccination with multiple ultra-narrow X-ray beams. Cancer Lett. 2025;608:217326. https:\/\/doi.org\/10.1016\/j.canlet.2024.217326.","journal-title":"Cancer Lett"},{"key":"8548_CR148","doi-asserted-by":"publisher","first-page":"eadk0642","DOI":"10.1126\/scitranslmed.adk0642","volume":"16","author":"JC Jagodinsky","year":"2024","unstructured":"Jagodinsky JC, Vera JM, Jin WJ, Shea AG, Clark PA, Sriramaneni RN, et al. Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade. Sci Transl Med. 2024;16:eadk0642. https:\/\/doi.org\/10.1126\/scitranslmed.adk0642.","journal-title":"Sci Transl Med"},{"key":"8548_CR149","doi-asserted-by":"publisher","first-page":"118107","DOI":"10.1016\/j.biopha.2025.118107","volume":"187","author":"Z Pisljar","year":"2025","unstructured":"Pisljar Z, Markelc B, Brezar SK, Bozic T, Sersa G, Cemazar M, et al. Partial versus whole tumor-volume irradiation in combination with immunotherapy: Comparable outcomes in immunosuppressed mouse models of oral squamous cell carcinoma. Biomed Pharmacother. 2025;187:118107. https:\/\/doi.org\/10.1016\/j.biopha.2025.118107.","journal-title":"Biomed Pharmacother"},{"key":"8548_CR150","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11060-005-9094-9","volume-title":"J Neuro-Oncol","author":"HM Smilowitz","year":"2006","unstructured":"Smilowitz HM, Blattmann H, Brauer-Krisch E, Bravin A, Di Michiel M, Gebbers J-O, et al. Synergy of gene-mediated immunoprophylaxis and microbeam radiation therapy for advanced intracerebral rat 9L gliosarcomas. J Neuro-Oncol. Volume 78. New York: Springer; 2006. pp. 135\u201343. https:\/\/doi.org\/10.1007\/s11060-005-9094-9."},{"key":"8548_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1697902","author":"J Hobson","year":"2025","unstructured":"Hobson J, Grams MP, Gicobi JK, Wigle D, Kottschade LA, Durham LA, et al. Case report: Complete pathologic response in advanced melanoma with SFRT and dual checkpoint inhibition. Front Oncol [Internet] Front. 2025. https:\/\/doi.org\/10.3389\/fonc.2025.1697902. [cited 2026 Mar 10];15.","journal-title":"Front Oncol [Internet] Front"},{"key":"8548_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.548132","author":"L Jiang","year":"2021","unstructured":"Jiang L, Li X, Zhang J, Li W, Dong F, Chen C, et al. Combined high-dose LATTICE radiation therapy and immune checkpoint blockade for advanced bulky tumors: The concept and a case report. Front Oncol [Internet] Front Media SA. 2021. https:\/\/doi.org\/10.3389\/fonc.2020.548132. [cited 2025 July 10];10.","journal-title":"Front Oncol [Internet] Front Media SA"},{"key":"8548_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1591424","author":"J Hu","year":"2025","unstructured":"Hu J, Jin Y, Wang M, Pang Y, Wang S, Xie X, et al. SFRT combined with immunotherapy for a growing hepatocellular carcinoma after the failure of anti-angiogenesis and anti-PD1 treatment: A case report. Front Oncol [Internet] Front. 2025. https:\/\/doi.org\/10.3389\/fonc.2025.1591424. [cited 2026 Mar 10];15.","journal-title":"Front Oncol [Internet] Front"},{"key":"8548_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2025.12.184","author":"W Liu","year":"2026","unstructured":"Liu W, Yu Y, Lin B, Xie R. Spatially fractionated radiotherapy combined with cadonilimab in cervical cancer with multisite metastasis: A case report. Asian J Surg [Internet]. 2026. https:\/\/doi.org\/10.1016\/j.asjsur.2025.12.184. [cited 2026 Mar 9].","journal-title":"Asian J Surg [Internet]"},{"key":"8548_CR155","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13014-019-1410-1","volume":"14","author":"S Tubin","year":"2019","unstructured":"Tubin S, Khan MK, Salerno G, Mourad WF, Yan W, Jeremic B. Mono-institutional phase 2 study of innovative stereotactic body RadioTherapy targeting PArtial tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: Profound non-targeted effects by sparing peri-tumoral immune microenvironment. Radiat Oncol Lond Engl. 2019;14:212. https:\/\/doi.org\/10.1186\/s13014-019-1410-1.","journal-title":"Radiat Oncol Lond Engl"},{"key":"8548_CR156","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2217\/imt-2020-0289","volume":"13","author":"M Massaccesi","year":"2021","unstructured":"Massaccesi M, Boldrini L, Romano A, Rossi E, Schinzari G, Lepre E, et al. Unconventional radiotherapy to enhance immunotherapy efficacy in bulky tumors: A case report. Immunotherapy Informa UK Ltd. 2021;13:1457\u201363. https:\/\/doi.org\/10.2217\/imt-2020-0289.","journal-title":"Immunotherapy Informa UK Ltd"},{"key":"8548_CR157","doi-asserted-by":"publisher","first-page":"e87415","DOI":"10.1172\/jci.insight.87415","volume":"1","author":"GS Herter-Sprie","year":"2016","unstructured":"Herter-Sprie GS, Koyama S, Korideck H, Hai J, Deng J, Li YY, et al. Synergy of radiotherapy and PD-1 blockade in kras-mutant lung cancer. JCI Insight. 2016;1:e87415. https:\/\/doi.org\/10.1172\/jci.insight.87415.","journal-title":"JCI Insight"},{"key":"8548_CR158","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","volume":"379","author":"SJ Antonia","year":"2018","unstructured":"Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, et al. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N Engl J Med. 2018;379:2342\u201350. https:\/\/doi.org\/10.1056\/NEJMoa1809697.","journal-title":"N Engl J Med"},{"key":"8548_CR159","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1056\/NEJMoa1112824","volume":"366","author":"MA Postow","year":"2012","unstructured":"Postow MA, Callahan MK, Barker CA, Yamada Y, Yuan J, Kitano S, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012;366:925\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1112824.","journal-title":"N Engl J Med"},{"key":"8548_CR160","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.eururo.2019.01.009","volume":"75","author":"N Sundahl","year":"2019","unstructured":"Sundahl N, Vandekerkhove G, Decaestecker K, Meireson A, De Visschere P, Fonteyne V, et al. Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma. Eur Urol. 2019;75:707\u201311. https:\/\/doi.org\/10.1016\/j.eururo.2019.01.009.","journal-title":"Eur Urol"},{"key":"8548_CR161","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jtho.2021.08.019","volume":"17","author":"CM Bestvina","year":"2022","unstructured":"Bestvina CM, Pointer KB, Karrison T, Al-Hallaq H, Hoffman PC, Jelinek MJ, et al. A phase 1 trial of concurrent or sequential ipilimumab, nivolumab, and stereotactic body radiotherapy in patients with stage IV NSCLC study. J Thorac Oncol. 2022;17:130\u201340. https:\/\/doi.org\/10.1016\/j.jtho.2021.08.019.","journal-title":"J Thorac Oncol"},{"key":"8548_CR162","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.7759\/cureus.389","volume":"7","author":"JM Blanco Suarez","year":"2015","unstructured":"Blanco Suarez JM, Amendola BE, Perez N, Amendola M, Wu X. The use of lattice radiation therapy (LRT) in the treatment of bulky tumors: A case report of a large metastatic mixed mullerian ovarian tumor. Cureus. 2015;7:e389. https:\/\/doi.org\/10.7759\/cureus.389.","journal-title":"Cureus"},{"key":"8548_CR163","doi-asserted-by":"publisher","first-page":"e4263","DOI":"10.7759\/cureus.4263","volume":"11","author":"BE Amendola","year":"2019","unstructured":"Amendola BE, Perez NC, Wu X, Amendola MA, Qureshi IZ. Safety and efficacy of lattice radiotherapy in voluminous non-small cell lung cancer. Cureus. 2019;11:e4263. https:\/\/doi.org\/10.7759\/cureus.4263.","journal-title":"Cureus"},{"key":"8548_CR164","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13566-012-0064-5","volume":"2","author":"A Kaiser","year":"2013","unstructured":"Kaiser A, Mohiuddin MM, Jackson GL. Dramatic response from neoadjuvant, spatially fractionated GRID radiotherapy (SFGRT) for large, high-grade extremity sarcoma. J Radiat Oncol. 2013;2:103\u20136. https:\/\/doi.org\/10.1007\/s13566-012-0064-5.","journal-title":"J Radiat Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08548-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08548-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08548-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:02:50Z","timestamp":1790982170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08548-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":164,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8548"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08548-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1235"}}